Edition:
India

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,384.20INR
20 Sep 2019
Change (% chg)

Rs-11.40 (-0.82%)
Prev Close
Rs1,395.60
Open
Rs1,381.00
Day's High
Rs1,423.00
Day's Low
Rs1,366.80
Volume
141,731
Avg. Vol
35,197
52-wk High
Rs1,694.00
52-wk Low
Rs1,130.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Jun 7,879.70 6.700
FY 2019 Jun 7,356.50 4.960
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 8,176.00 8,176.00 8,176.00 --
Year Ending Mar-19 5 32,594.00 33,724.00 31,949.00 --
Year Ending Mar-20 5 35,079.00 36,845.00 34,140.00 36,746.40
Year Ending Mar-21 5 38,820.00 41,028.00 36,904.00 37,404.00
Earnings (per share)
Year Ending Mar-19 5 24.77 26.60 24.00 --
Year Ending Mar-20 5 28.16 30.20 25.59 31.42
Year Ending Mar-21 5 32.33 38.30 28.97 29.12
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 29.88 32.66
P/E High - Last 5 Yrs. -- 42.97 47.31
P/E Low - Last 5 Yrs. -- 23.37 23.88
Beta 0.17 0.89 0.89
Price to Sales (TTM) 14.01 6.26 7.91
Price to Book (MRQ) -- 5.26 5.38
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) 174.34 23.51 24.36
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield 1.24 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.44 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) 0.00 42.60 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.58 42.97
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.78 10.31
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.94 10.20
Total Debt to Equity (MRQ) -- 11.63 14.55
Interest Coverage (TTM) -- 33.56 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 51.86 52.24
Gross Margin - 5 Yr. Avg. -- 49.68 50.41
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 17.36 13.12
Operating Margin (TTM) 33.89 13.68 6.81
Operating Margin - 5 Yr. Avg. -- 13.91 8.92
Pre-Tax Margin (TTM) 33.89 12.30 5.99
Pre-Tax Margin - 5 Yr. Avg. -- 14.32 9.22
Net Profit Margin (TTM) 23.12 9.08 2.63
Net Profit Margin - 5 Yr. Avg. -- 10.75 5.58
Effective Tax Rate (TTM) 31.77 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 992,970,939 887,291,347
Net Income/Employee (TTM) 718,922 114,017,310 101,845,047
Receivable Turnover (TTM) -- 5.96 5.93
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.17
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.89 14.48
Return on Investment - 5 Yr. Avg. -- 16.86 16.02
Return on Equity (TTM) -- 16.01 15.78
Return on Equity - 5 Yr. Avg. -- 17.66 17.01
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 25
13 Week -6.52 -7.86 99 42
26 Week -11.71 -17.56 99 42
52 Week -17.27 -26.91 99 12
YTD -11.53 -25.96 99 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.97%
# of Holders: 19
Total Shares Held: 30,433,925
3 Mo. Net Change: -29,729
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 6
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.